|
| |
androgen receptor GTX Pages on BioPortfolio:
BioPortfolio - GTX
GTx also is developing ostarine, a first-in-class selective androgen receptor modulator, or SARM. GTx believes that ostarine has the potential to treat a ...
http://www.bioportfolio.com/biocorporate/32439-GTX.html...
|
Biotechnology News Avi qca. cook. 5126. stent. gtx. restenosi. Search
Life Sciences: Scientists at GTx publish research in life sciences ... S-22, regulate androgen receptor function through distinct genomic and nongenomic ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - GTx, Inc.
GTx also is developing ostarine, a selective androgen receptor modulator, or SARM, for a variety of indications including muscle wasting and bone loss in ...
http://www.bioportfolio.com/biocorporate/23753-GTx,_Inc..htm...
|
Biotechnology News oncology cancer gtx. ostarin. sarm. 2866 ...
GTx Announces Investigational Ostarine MK-2866 Met the Primary Endpoint in the Phase II ... an investigational selective androgen receptor modulator (SARM),
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - GTx, Inc. - Profile
GTx also is developing. ostarine, a selective androgen receptor modulator, or SARM, for a variety of indications including muscle ...
http://www.bioportfolio.com/biocorporate/23753-GTx,%252BInc....
|
BioPortfolio - androgen receptor 2008
Androgen Receptor (AR) ligands are important for the development and... 20th September, 2008, Preclinical Research and Development, GTx, Inc., . ...
http://www.bioportfolio.com/search/androgen_receptor_2008.ht...
|
Natural bioactive compounds as therapeutic candidates for benign ...
Andarine, Androgen receptor ligand, GTx. micrin, Unidentified, Endocrine. AS- 601811, 5-a-reductase inhibitor, Serono. NCX-2111, NO donor/COX inhibitor ...
http://www.bioportfolio.com/LeadDiscovery/nat1.htm...
|
Obesity Lack of Reimbursement Limits Market Potential
ANDROGEN RECEPTOR AGONISTS, GTX 194. AMG076 194. QRX431 194. BDC03 194. RESVERATROL (SRT501) 195. PRX07034 195. TM30338 195. GT389255 195 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_670.html...
|
BioPortfolio - estrogen receptor karo
BioPortfolio - androgen receptor GTX ... and GTx-878, an estrogen receptor beta agonist, a new class of drugs for the . ... GTx Technologies and Karo Bio ...
http://www.bioportfolio.com/search/estrogen_receptor_karo.ht...
|
BioPortfolio - radio ligand assay
Andarine, Androgen receptor ligand, GTx. micrin, Unidentified, Endocrine ... http://www.bioportfolio.com/LeadDiscovery/nat1.htm. ...
http://www.bioportfolio.com/search/radio_ligand_assay.html...
|
Results from other life science and pharmaceutical sites:
Merck News Item
6 Nov 2007 ... GTx has agreed to a collaboration with Merck & Co., Inc. for the development and global commercialization of selective androgen receptor ...
http://www.merck.com/newsroom/press_releases/research_and_de...
|
BioPortfolio - GTX
GTx also is developing ostarine, a first-in-class selective androgen receptor modulator, or SARM. GTx believes that ostarine has the potential to treat a ...
http://www.bioportfolio.com/biocorporate/32439-GTX.html...
|
Live Call: GTx, Inc. Earnings Conference Call (Q3 2008) - Yahoo ...
It also develops Ostarine, a selective androgen receptor modulator (SARM); and GTx-838 for the treatment of various indications associated with muscle ...
http://biz.yahoo.com/cc/1/98631.html...
|
GTx, Inc. Completes Enrollment Of Phase II Ostarine Trial - News ...
GTx is developing ostarine, a selective androgen receptor modulator, or SARM, for muscle wasting and bone loss indications. Ostarine is currently being ...
http://www.biospace.com/news_story.aspx?NewsEntityId=24835...
|
BioPortfolio - GTx, Inc.
GTx also is developing ostarine, a selective androgen receptor modulator, or SARM, for a variety of indications including muscle wasting and bone loss in ...
http://www.bioportfolio.com/biocorporate/23753-GTx,_Inc..htm...
|
GTx, Inc. Says Muscle Drug Meets Main Goal of Mid-Stage Trial ...
In December 2007, GTx and Merck & Co., Inc. formed a collaboration to discover and develop selective androgen receptor modulators (SARMs), a new class of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=112711...
|
BioPortfolio - GTx, Inc. - Profile
GTx also is developing. ostarine, a selective androgen receptor modulator, or SARM, for a variety of indications including muscle ...
http://www.bioportfolio.com/biocorporate/23753-GTx,%252BInc....
|
Steroidal androgens and nonsteroidal, tissue-selective androgen ...
Preclinical Research and Development, GTx, Inc., 3 North Dunlap Street, Memphis, Tennessee 38163, USA. Androgen receptor (AR) ligands are important for the ...
http://www.ncbi.nlm.nih.gov/pubmed/18801930...
|
BioWorld Today
7 Nov 2007 ... Inc. in a deal worth at least $500 million to develop and commercialize selective androgen receptor modulators (SARMs), a new class of drugs ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
Ockham's Razor and Selective Androgen Receptor Modulators (SARMs ...
3 Vice-President of Preclinical Research and Development GTx, Inc. ... The androgen receptor (AR) is a member of the nuclear receptor superfamily, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20...
|
|
